APO Research
Talk to an analyst

APO RESEARCH · REPORT

HPV Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global HPV Vaccines Industry Growth and Trends Forecast to 2032

22 December 2025105 pages

Choose your research edition.

Industry ResearchHPV Vaccines Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal HPV Vaccines Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal HPV Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HPV Vaccines Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal HPV Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global HPV Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for HPV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for HPV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HPV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of HPV Vaccines include Johnson & Johnson, Merck, Pfizer, GlaxoSmithKline, Serum Institute, Sanofi Pasteur, MedImmune, Emergent BioSolutions and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global HPV Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The HPV Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global HPV Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to HPV Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global HPV Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

HPV Vaccines Market by Company

Johnson & Johnson

Merck

Pfizer

GlaxoSmithKline

Serum Institute

Sanofi Pasteur

MedImmune

Emergent BioSolutions

CSL

Astellas Pharma

HPV Vaccines Segment by Type

Adolescents

Adults

HPV Vaccines Segment by Application

Male

Female

HPV Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HPV Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of HPV Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of HPV Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Adolescents Table 2. Major Company of Adults Table 3. Global HPV Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global HPV Vaccines Sales by Type (2021-2026) & (k units) Table 5. Global HPV Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global HPV Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global HPV Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global HPV Vaccines Price by Type (2021-2026) & (US$/unit) Table 9. Global HPV Vaccines Sales by Type (2027-2032) & (k units) Table 10. Global HPV Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global HPV Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global HPV Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global HPV Vaccines Price by Type (2027-2032) & (US$/unit) Table 14. North America HPV Vaccines Sales by Type (2021-2026) & (k units) Table 15. North America HPV Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe HPV Vaccines Sales by Type (2021-2026) & (k units) Table 17. Europe HPV Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific HPV Vaccines Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific HPV Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America HPV Vaccines Sales by Type (2021-2026) & (k units) Table 21. Latin America HPV Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa HPV Vaccines Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa HPV Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. HPV Vaccines Industry Trends Table 25. HPV Vaccines Industry Drivers Table 26. HPV Vaccines Industry Opportunities and Challenges Table 27. HPV Vaccines Industry Restraints Table 28. Global HPV Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global HPV Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global HPV Vaccines Sales by Company (2021-2026) & (k units) Table 31. Global HPV Vaccines Sales Share by Company (2021-2026) Table 32. Global HPV Vaccines Market Price by Company (2021-2026) & (US$/unit) Table 33. Global HPV Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global HPV Vaccines Major Company Production Sites and Headquarters Table 35. Global HPV Vaccines Company, Product Type & Application Table 36. Global HPV Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global HPV Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global HPV Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global HPV Vaccines Sales by Region (2021-2026) & (k units) Table 41. Global HPV Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global HPV Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global HPV Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global HPV Vaccines Sales by Region (2027-2032) & (k units) Table 46. Global HPV Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global HPV Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global HPV Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global HPV Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global HPV Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global HPV Vaccines Sales by Application (2021-2026) & (k units) Table 52. Global HPV Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global HPV Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global HPV Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global HPV Vaccines Price by Application (2021-2026) & (US$/unit) Table 56. Global HPV Vaccines Sales by Application (2027-2032) & (k units) Table 57. Global HPV Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global HPV Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global HPV Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global HPV Vaccines Price by Application (2027-2032) & (US$/unit) Table 61. North America HPV Vaccines Sales by Application (2021-2026) & (k units) Table 62. North America HPV Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe HPV Vaccines Sales by Application (2021-2026) & (k units) Table 64. Europe HPV Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific HPV Vaccines Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific HPV Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America HPV Vaccines Sales by Application (2021-2026) & (k units) Table 68. Latin America HPV Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa HPV Vaccines Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa HPV Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Johnson & Johnson HPV Vaccines Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Merck HPV Vaccines Product Portfolio Table 80. Merck Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Pfizer HPV Vaccines Product Portfolio Table 85. Pfizer Recent Development Table 86. GlaxoSmithKline Company Information Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline HPV Vaccines Product Portfolio Table 90. GlaxoSmithKline Recent Development Table 91. Serum Institute Company Information Table 92. Serum Institute Business Overview Table 93. Serum Institute HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Serum Institute HPV Vaccines Product Portfolio Table 95. Serum Institute Recent Development Table 96. Sanofi Pasteur Company Information Table 97. Sanofi Pasteur Business Overview Table 98. Sanofi Pasteur HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Sanofi Pasteur HPV Vaccines Product Portfolio Table 100. Sanofi Pasteur Recent Development Table 101. MedImmune Company Information Table 102. MedImmune Business Overview Table 103. MedImmune HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. MedImmune HPV Vaccines Product Portfolio Table 105. MedImmune Recent Development Table 106. Emergent BioSolutions Company Information Table 107. Emergent BioSolutions Business Overview Table 108. Emergent BioSolutions HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Emergent BioSolutions HPV Vaccines Product Portfolio Table 110. Emergent BioSolutions Recent Development Table 111. CSL Company Information Table 112. CSL Business Overview Table 113. CSL HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. CSL HPV Vaccines Product Portfolio Table 115. CSL Recent Development Table 116. Astellas Pharma Company Information Table 117. Astellas Pharma Business Overview Table 118. Astellas Pharma HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Astellas Pharma HPV Vaccines Product Portfolio Table 120. Astellas Pharma Recent Development Table 121. North America HPV Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. North America HPV Vaccines Sales by Country (2021-2026) & (k units) Table 123. North America HPV Vaccines Sales Market Share by Country (2021-2026) Table 124. North America HPV Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 125. North America HPV Vaccines Sales Market Share Forecast by Country (2027-2032) Table 126. North America HPV Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America HPV Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 128. North America HPV Vaccines Market Share by Country (2021-2026) Table 129. North America HPV Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America HPV Vaccines Market Share Forecast by Country (2027-2032) Table 131. Europe HPV Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Europe HPV Vaccines Sales by Country (2021-2026) & (k units) Table 133. Europe HPV Vaccines Sales Market Share by Country (2021-2026) Table 134. Europe HPV Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 135. Europe HPV Vaccines Sales Market Share Forecast by Country (2027-2032) Table 136. Europe HPV Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe HPV Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe HPV Vaccines Market Share by Country (2021-2026) Table 139. Europe HPV Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe HPV Vaccines Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific HPV Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific HPV Vaccines Sales by Country (2021-2026) & (k units) Table 143. Asia-Pacific HPV Vaccines Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific HPV Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 145. Asia-Pacific HPV Vaccines Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific HPV Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific HPV Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific HPV Vaccines Market Share by Country (2021-2026) Table 149. Asia-Pacific HPV Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific HPV Vaccines Market Share Forecast by Country (2027-2032) Table 151. Latin America HPV Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Latin America HPV Vaccines Sales by Country (2021-2026) & (k units) Table 153. Latin America HPV Vaccines Sales Market Share by Country (2021-2026) Table 154. Latin America HPV Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 155. Latin America HPV Vaccines Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America HPV Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America HPV Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America HPV Vaccines Market Share by Country (2021-2026) Table 159. Latin America HPV Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America HPV Vaccines Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa HPV Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa HPV Vaccines Sales by Country (2021-2026) & (k units) Table 163. Middle East and Africa HPV Vaccines Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa HPV Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 165. Middle East and Africa HPV Vaccines Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa HPV Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa HPV Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa HPV Vaccines Market Share by Country (2021-2026) Table 169. Middle East and Africa HPV Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa HPV Vaccines Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. HPV Vaccines Distributors List Table 174. HPV Vaccines Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. HPV Vaccines Image Figure 2. Global HPV Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HPV Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global HPV Vaccines Sales (2021-2032) & (k units) Figure 5. Adolescents Image Figure 6. Global Adolescents Sales YoY Growth (2021-2032) & (k units) Figure 7. Adults Image Figure 8. Global Adults Sales YoY Growth (2021-2032) & (k units) Figure 9. Global HPV Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global HPV Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America HPV Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America HPV Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe HPV Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe HPV Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific HPV Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific HPV Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America HPV Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America HPV Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa HPV Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa HPV Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 HPV Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Male Image Figure 24. Global Male Sales YoY Growth (2021-2032) & (k units) Figure 25. Female Image Figure 26. Global Female Sales YoY Growth (2021-2032) & (k units) Figure 27. Global HPV Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global HPV Vaccines Market Share by Application 2025 VS 2032 Figure 29. North America HPV Vaccines Sales Market Share in Volume by Application in 2025 Figure 30. North America HPV Vaccines Sales Market Share in Value by Application in 2025 Figure 31. Europe HPV Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. Europe HPV Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific HPV Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific HPV Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Latin America HPV Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Latin America HPV Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa HPV Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa HPV Vaccines Sales Market Share in Value by Application in 2025 Figure 39. North America HPV Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America HPV Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America HPV Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe HPV Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe HPV Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe HPV Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific HPV Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific HPV Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific HPV Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America HPV Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America HPV Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America HPV Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa HPV Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa HPV Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa HPV Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. HPV Vaccines Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. HPV Vaccines Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Adolescents
  • Adults
Applications
  • Male
  • Female
Companies covered
  • Johnson & Johnson
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Serum Institute
  • Sanofi Pasteur
  • MedImmune
  • Emergent BioSolutions
  • CSL
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global HPV Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global HPV Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 HPV Vaccines Market by Type
  6. 1.3.1 Adolescents
  7. 1.3.2 Adults
  8. 1.4 Global HPV Vaccines Market Size by Type
  9. 1.4.1 Global HPV Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global HPV Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global HPV Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America HPV Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe HPV Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific HPV Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America HPV Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa HPV Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 HPV Vaccines Industry Trends
  2. 2.2 HPV Vaccines Industry Drivers
  3. 2.3 HPV Vaccines Industry Opportunities and Challenges
  4. 2.4 HPV Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by HPV Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by HPV Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by HPV Vaccines Price (2021-2026)
  4. 3.4 Global HPV Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global HPV Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global HPV Vaccines Company, Product Type & Application
  7. 3.7 Global HPV Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global HPV Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 HPV Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 HPV Vaccines Tier 1, Tier 2, and Tier 3
4 HPV Vaccines Regional Status and Outlook
  1. 4.1 Global HPV Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global HPV Vaccines Historic Market Size by Region
  3. 4.2.1 Global HPV Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global HPV Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global HPV Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global HPV Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global HPV Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global HPV Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global HPV Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 HPV Vaccines by Application
  1. 5.1 HPV Vaccines Market by Application
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global HPV Vaccines Market Size by Application
  5. 5.2.1 Global HPV Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global HPV Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global HPV Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America HPV Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe HPV Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific HPV Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America HPV Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa HPV Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson HPV Vaccines Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck HPV Vaccines Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer HPV Vaccines Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline HPV Vaccines Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 Serum Institute
  26. 6.5.1 Serum Institute Company Information
  27. 6.5.2 Serum Institute Business Overview
  28. 6.5.3 Serum Institute HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Serum Institute HPV Vaccines Product Portfolio
  30. 6.5.5 Serum Institute Recent Developments
  31. 6.6 Sanofi Pasteur
  32. 6.6.1 Sanofi Pasteur Company Information
  33. 6.6.2 Sanofi Pasteur Business Overview
  34. 6.6.3 Sanofi Pasteur HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi Pasteur HPV Vaccines Product Portfolio
  36. 6.6.5 Sanofi Pasteur Recent Developments
  37. 6.7 MedImmune
  38. 6.7.1 MedImmune Company Information
  39. 6.7.2 MedImmune Business Overview
  40. 6.7.3 MedImmune HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 MedImmune HPV Vaccines Product Portfolio
  42. 6.7.5 MedImmune Recent Developments
  43. 6.8 Emergent BioSolutions
  44. 6.8.1 Emergent BioSolutions Company Information
  45. 6.8.2 Emergent BioSolutions Business Overview
  46. 6.8.3 Emergent BioSolutions HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Emergent BioSolutions HPV Vaccines Product Portfolio
  48. 6.8.5 Emergent BioSolutions Recent Developments
  49. 6.9 CSL
  50. 6.9.1 CSL Company Information
  51. 6.9.2 CSL Business Overview
  52. 6.9.3 CSL HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 CSL HPV Vaccines Product Portfolio
  54. 6.9.5 CSL Recent Developments
  55. 6.10 Astellas Pharma
  56. 6.10.1 Astellas Pharma Company Information
  57. 6.10.2 Astellas Pharma Business Overview
  58. 6.10.3 Astellas Pharma HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Astellas Pharma HPV Vaccines Product Portfolio
  60. 6.10.5 Astellas Pharma Recent Developments
7 North America by Country
  1. 7.1 North America HPV Vaccines Sales by Country
  2. 7.1.1 North America HPV Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America HPV Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America HPV Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America HPV Vaccines Market Size by Country
  6. 7.2.1 North America HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America HPV Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America HPV Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe HPV Vaccines Sales by Country
  2. 8.1.1 Europe HPV Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe HPV Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe HPV Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe HPV Vaccines Market Size by Country
  6. 8.2.1 Europe HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe HPV Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe HPV Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific HPV Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific HPV Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific HPV Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific HPV Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific HPV Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific HPV Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific HPV Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America HPV Vaccines Sales by Country
  2. 10.1.1 South America HPV Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America HPV Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America HPV Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America HPV Vaccines Market Size by Country
  6. 10.2.1 South America HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America HPV Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America HPV Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa HPV Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa HPV Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa HPV Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa HPV Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa HPV Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa HPV Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa HPV Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa HPV Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 HPV Vaccines Value Chain Analysis
  2. 12.1.1 HPV Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 HPV Vaccines Production Mode & Process
  7. 12.2 HPV Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 HPV Vaccines Distributors
  10. 12.2.3 HPV Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst